Cutting edge:: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis

被引:234
作者
Ulbrecht, M
Martinozzi, S
Grzeschik, M
Hengel, H
Ellwart, JW
Pla, M
Weiss, EH
机构
[1] Inst Anthropol & Humangenet, D-80333 Munich, Germany
[2] Hop St Louis, INSERM U462, Mouse Immunogenet, Inst Hematol, Paris, France
[3] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany
[4] GSF, Forschungszentrum, Inst Expt Hamatol, Munich, Germany
关键词
D O I
10.4049/jimmunol.164.10.5019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human CMV has evolved multiple strategies to interfere with immune recognition of the host. A variety of mechanisms target Ag presentation by MHC class I molecules resulting in a reduced class I cell-surface expression, This down-regulation of class I molecules is expected to trigger NK cytotoxicity, which would have to be counteracted by the virus to establish long-term infection. Here we describe that the human CMV open reading frame UL40 encodes a canonical ligand for HLA-E, identical with the HLA-Cw03 signal sequence-derived peptide. Expression of UL40 in HLA-E-positive target cells conferred resistance to NK cell lysis via the CD94/NKG2A receptor. Generation of the UL40-derived HLA-E ligand was also observed in TAP-deficient cells, The presence of a functional TAP-independent HLA-E ligand in the UL40 signal sequence implicates this viral gene as an important negative regulator of NK activity.
引用
收藏
页码:5019 / 5022
页数:4
相关论文
共 25 条
  • [1] The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
    Ahn, K
    Gruhler, A
    Galocha, B
    Jones, TR
    Wiertz, EJHJ
    Ploegh, HL
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. IMMUNITY, 1997, 6 (05) : 613 - 621
  • [2] Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
    Ahn, KS
    Angulo, A
    Ghazal, P
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 10990 - 10995
  • [3] SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS
    BIRON, CA
    BYRON, KS
    SULLIVAN, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) : 1731 - 1735
  • [4] Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
    Borrego, F
    Ulbrecht, M
    Weiss, EH
    Coligan, JE
    Brooks, AG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05) : 813 - 818
  • [5] HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
    Braud, VM
    Allan, DSJ
    O'Callaghan, CA
    Söderström, K
    D'Andrea, A
    Ogg, GS
    Lazetic, S
    Young, NT
    Bell, JI
    Phillips, JH
    Lanier, LL
    McMichael, AJ
    [J]. NATURE, 1998, 391 (6669) : 795 - 799
  • [6] Brooks AG, 1999, J IMMUNOL, V162, P305
  • [7] DNA microarrays of the complex human cytomegalovirus genome: Profiling kinetic class with drug sensitivity of viral gene expression
    Chambers, J
    Angulo, A
    Amaratunga, D
    Guo, HQ
    Jiang, Y
    Wan, JS
    Bittner, A
    Frueh, K
    Jackson, MR
    Peterson, PA
    Erlander, MG
    Ghazal, P
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (07) : 5757 - 5766
  • [8] The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
    Cohen, GB
    Gandhi, RT
    Davis, DM
    Mandelboim, O
    Chen, BK
    Strominger, JL
    Baltimore, D
    [J]. IMMUNITY, 1999, 10 (06) : 661 - 671
  • [9] A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
    Cosman, D
    Fanger, N
    Borges, L
    Kubin, M
    Chin, W
    Peterson, L
    Hsu, ML
    [J]. IMMUNITY, 1997, 7 (02) : 273 - 282
  • [10] CYTOKINES RESTORE MHC CLASS-I COMPLEX-FORMATION AND CONTROL ANTIGEN PRESENTATION IN HUMAN CYTOMEGALOVIRUS-INFECTED CELLS
    HENGEL, H
    ESSLINGER, C
    POOL, J
    GOULMY, E
    KOSZINOWSKI, UH
    [J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 2987 - 2997